DENVER, CO / ACCESSWIRE / January 9, 2018 / BioLargo®, Inc. (OTCQB: BLGO):
More
than one million industrial sites in the U.S. generate unpleasant odors
as a normal part of their operations. Although the U.S. waste handling
industry makes up only a small part of that million, its revenues exceed $75 Billion
annually. Landfills, transfer stations, composting operations, and
countless trash containers harbor some of the most putrescent odors
imaginable. With increasing urbanization, our neighborhoods creep closer
and closer to these facilities, triggering more frequent complaints,
regulatory violations, and in extreme situations, litigation.
To
combat regulatory violations, neighbor complaints, and lawsuits, the
waste handling industry has historically relied on odor control products
that use strong fragrances to try to overpower unpleasant odors. Some
companies have even installed expensive covers and enclosures to
mitigate the negative impact of odors on their neighbors. While
solutions like these have historically been considered the “best
available,” these old strategies do not go to the root of the problem –
the odor-causing compounds themselves – and therefore tend to fail.
While some enzyme-based solutions do eliminate some odor-causing
compounds, they often have a limited range of activity, take some time
to work, and can be costly. The industry has been ripe for innovation to
find a product that actually works to eliminate the odor causing
compounds like hydrogen sulfides and ammonia.
BioLargo®, Inc.
(OTCQB: BLGO) first launched CupriDyne Clean in May of 2016. In the
first year of its commercialization the company proved the commercial
viability of CupriDyne Clean. By July of 2017, it had landed as clients 3
of the top 10 companies in the solid waste handling industry. The
company’s filings show CupriDyne Clean sales have doubled each of the
first three quarters of 2017.
With sales to waste handling
facilities gaining traction, BioLargo reports it is looking to sell
CupriDyne Clean into new industries. Its last quarterly report stated
that it was conducting trials in the wastewater treatment industry, and
its recent shareholder letter indicated it had secured its first
flagship clients. Wastewater treatment is a big industry – there are
more than 900 public wastewater treatment facilities in California alone.
2015 Census figures report 740,303 active firms (including
municipalities and private companies) in California, representing just
under $1 billion in payroll. There are more than 6,000 California firms
employing more than 500 people in the industry. According to Global
Information, a market research company, the global municipal and
industrial wastewater sludge treatment equipment and
wastewater/sludge-based odor control equipment is estimated to have been
$6.5 billion in 2013, and reached an estimated $6.9 billion by year-end
2014. The compound annual growth rate (CAGR) during the forecast
period, 2014 to 2019, is estimated to be 5.9%. At this rate, the market
value could reach $9.2 billion by 2019.
In a special Waste360 report,
Joseph Provenzano, President of BioLargo’s Odor-No-More® division
explained, “CupriDyne Clean oxidizes all volatile organic compounds
(VOCs), amines, sulfur compounds, fatty acids, and mercaptans prevalent
at sites that process organics. Our products are broad spectrum and work
indiscriminately on all organically derived odors. They eliminate odors
rather than cover them. Most other industry products use fragrance to
mask odors, often exacerbating the problem. Our products are not masking
agents. Rather, this green technology breaks down odorous compounds
through oxidation. Odor reduction is immediate and it is safe.”
BioLargo
is a sustainable engineering services, science and technology company
with multiple irons in the fire, with its focus on clean air, clean
water and advanced wound care. According to its year-end Shareholder Letter,
its industrial odor eliminator product CupriDyne is poised for
exponential revenue growth. Its new sustainable environmental
engineering services team is commercial and has landed its first
customer contracts for 2018. Its advanced wound care products are in FDA
review with expectations to go commercial in early 2018. Its
award-winning advanced water treatment technology is targeting late 2018
to go commercial. BioLargo is a company to watch as it continues to
build its business and focus on its mission to “Make Life Better”.
Legal Disclaimer:
Except
for the historical information presented herein, matters discussed in
this release contain forward-looking statements that are subject to
certain risks and uncertainties that could cause actual results to
differ materially from any future results, performance or achievements
expressed or implied by such statements. Flathead Business Solutions
LLC, which owns tamarackadvisorsinc.com,
is not registered with any financial or securities regulatory authority
and does not provide nor claims to provide investment advice or
recommendations to readers of this release. Flathead Business Solutions
LLC may from time to time have a position in the securities mentioned
herein and may increase or decrease such positions without notice. For
making specific investment decisions, readers should seek their own
advice. Flathead Business Solutions LLC may be compensated for its
services in the form of cash-based compensation or equity securities in
the companies it writes about, or a combination of the two. For full
disclosure please visit http://tamarackadvisorsinc.com/legal-disclaimer/.
SOURCE: Tamarack Advisors